Targeting inflammatory pathways may reduce tumor aggressiveness and preserve ovarian function, playing a dual role in managing ovarian cancer progression through the inhibition of HIF-1α-driven inflammation and in the treatment of female infertility by safeguarding ovarian function and minimizing reproductive tissue damage (Table 2). Here, HIF1A is linked to female infertility.